Soares and colleagues [63] analyzed the status of the topoisomerase II alpha gene (TOP2A) in the FMCs referred above, as the status of these two genes, ERBB2 and TOP2A, is usually “in accordance” in some human breast cancers [64,65]. This evidence concerns the gene ERBB2 and breast carcinoma.